Biopersistence of inhaled nickel oxide nanoparticles in rat lung.
In order to investigate whether or not airborne nanoparticles with a minimum agglomeration could be used for exposure tests on animals, we developed a nanoparticle generation system and examined the biological effects of the particles in an inhalation study. The generation system was composed of an ultrasonic nebulizer and diffusion dryers, and 30 Wistar male rats were exposed to nickel oxide (NiO) nanoparticles for 4 wk (6 h/day). The geometric mean diameter of the particles and the daily average exposure concentration determined by a combination of a differential mobility analyzer and a condensation nucleus counter in the exposure chamber were 139 +/- 12 nm and 1.0 +/- 0.5 x 10(5) particles/cm3, respectively. At 4 days and 1 and 3 mo after the inhalation, each group of 10 rats were sacrificed and NiO nanoparticles deposited in the lung were determined by chemical analysis and the biopersistence (biological half time) was calculated. The deposited amount of NiO nanoparticles in the rat lungs at 4 days after the inhalation was 29 +/- 4 microg. The retained particle amount in the rat lungs after the inhalation exponentially decreased and the calculated biological half time was 62 days. The histopathological change was not severe just after the inhalation nor throughout the observation time. We concluded that nanoparticles with a minimum agglomeration were dispersed stably in the chamber and exposed to rats for 4 wk and that deposited amounts in the rat lungs and the biopersistence of the particles and the biological response in lung were detected.
Oyabu
T
T
Institute of Industrial Ecological Sciences, University of Occupational and Environmental Health, Kitakyushu, Japan. toyabu@med.uoeh-u.ac.jp
Ogami
A
A
Morimoto
Y
Y
Shimada
M
M
Lenggoro
W
W
Okuyama
K
K
Tanaka
I
I
D000818:Animals; D001273:Atmosphere Exposure Chambers; D019570:Inhalation Exposure; D008168:Lung / Q000187:drug effects / Q000378:metabolism*; D008297:Male; D053758:Nanoparticles / Q000008:administration & dosage; D009330:Nebulizers and Vaporizers; D009532:Nickel / Q000008:administration & dosage / Q000493:pharmacokinetics*; D010316:Particle Size; D051381:Rats; D017208:Rats, Wistar; D014018:Tissue Distribution / Q000187:drug effects / Q000502:physiology
D009532:Nickel; C028007:nickel monoxide